UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

JAVELIN renal 101: A randomized, phase III study of avelumab + axitinib vs sunitinib as first-line treatment of advanced renal cell carcinoma (aRCC)

Annals of oncology, 2018-10, Vol.29, p.viii724-viii724

2018

Volltextzugriff (PDF)

Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial

ESMO open, 2021-06, Vol.6 (3), p.100101, Article 100101

2021

Volltextzugriff (PDF)

Improved Expression in Hematopoietic and Lymphoid Cells in Mice After Transplantation of Bone Marrow Transduced With a Modified Retroviral Vector

Blood, 1999-11, Vol.94 (10), p.3349-3357

1999

Volltextzugriff (PDF)

Peptide Delivery to Tissues via Reversibly Linked Protein Transduction Sequences

BioTechniques, 2002-07, Vol.33 (1), p.190-194

2002

Volltextzugriff (PDF)

Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells

Journal of Virology, 1997-12, Vol.71 (12), p.9466-9474

1997

Volltextzugriff (PDF)

The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion

The Journal of immunology (1950), 1991-11, Vol.147 (9), p.2892-2901

1991

Volltextzugriff (PDF)

In vivo restoration of laminin 5 beta 3 expression and function in junctional epidermolysis bullosa

Proceedings of the National Academy of Sciences - PNAS, 2001-04, Vol.98 (9), p.5193-5198

2001

Volltextzugriff (PDF)

Consistent, Persistent Expression from Modified Retroviral Vectors in Murine Hematopoietic Stem Cells

Proceedings of the National Academy of Sciences - PNAS, 1998-08, Vol.95 (17), p.10182-10187

1998

Volltextzugriff (PDF)

Sustainable systemic delivery via a single injection of lentivirus into human skin tissue

Human gene therapy, 2001-08, Vol.12 (12), p.1551-1558

2001

Volltextzugriff (PDF)

Validation of biomarkers to predict response to immunotherapy in cancer: Volume I — pre-analytical and analytical validation

Journal for immunotherapy of cancer, 2016-11, Vol.4 (1), p.76-76, Article 76

2016

Volltextzugriff (PDF)

Viral antigen stimulation of the production of human monokines capable of regulating HIV1 expression

The Journal of immunology (1950), 1989-07, Vol.143 (2), p.470-475

1989

Volltextzugriff (PDF)

908PDPrimary renal tumour shrinkage in patients (pts) who did not undergo upfront cytoreductive nephrectomy (uCN): Subgroup analysis from the phase III JAVELIN Renal 101 trial of first-line avelumab + axitinib (A + Ax) vs sunitinib (S) for advanced renal cell carcinoma (aRCC)

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

910PDEfficacy and biomarker analysis of patients (pts) with advanced renal cell carcinoma (aRCC) with sarcomatoid histology (sRCC): Subgroup analysis from the phase III JAVELIN renal 101 trial of first-line avelumab plus axitinib (A + Ax) vs sunitinib (S)

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

LBA6_PRJAVELIN renal 101: A randomized, phase III study of avelumab + axitinib vs sunitinib as first-line treatment of advanced renal cell carcinoma (aRCC)

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Validation of biomarkers to predict response to immunotherapy in cancer: Volume II — clinical validation and regulatory considerations

Journal for Immunotherapy of Cancer, 2016-11, Vol.4 (1), p.77-77, Article 77

2016

Volltextzugriff (PDF)

Use of human tissue to assess the oncogenic activity of melanoma-associated mutations

Nature genetics, 2005-07, Vol.37 (7), p.745-749

2005

Volltextzugriff (PDF)

Erratum to ‘Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial’: [ESMO Open Volume 6, Issue 3, June 2021, 100101]

ESMO open, 2021-08, Vol.6 (4), p.100177-100177, Article 100177

2021

Volltextzugriff (PDF)

Impact of Laminin 5 beta 3 Gene versus Protein Replacement on Gene Expression Patterns in Junctional Epidermolysis Bullosa

Human gene therapy, 2001-07, Vol.12 (11), p.1443-1448

2001

Volltextzugriff (PDF)

In vivo Restoration of Laminin 5 β3 Expression and Function in Junctional Epidermolysis Bullosa

Proceedings of the National Academy of Sciences - PNAS, 2001-04, Vol.98 (9), p.5193-5198

2001

Volltextzugriff (PDF)

High-Resolution Analysis of Cytosine Methylation in the 5′ Long Terminal Repeat of Retroviral Vectors

Human gene therapy, 1998-11, Vol.9 (16), p.2321-2330

1998

Volltextzugriff (PDF)

Selective in vitro and in vivo anti-tumor activity of PRLX 93936 in biological models of melanoma and ovarian cancer

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.14586-14586

2008

Volltextzugriff (PDF)

Impact of laminin 5 beta3 gene versus protein replacement on gene expression patterns in junctional epidermolysis bullosa

Human gene therapy, 2001-07, Vol.12 (11), p.1443-1448

2001

Volltextzugriff (PDF)

Genetic associations with adverse events from anti-tumor necrosis factor therapy in inflammatory bowel disease patients

World journal of gastroenterology : WJG, 2017-10, Vol.23 (40), p.7265-7273

2017

Volltextzugriff (PDF)

High-resolution analysis of cytosine methylation in the 5ĺong terminal repeat of retroviral vectors

Human gene therapy, 1998-11, Vol.9 (16), p.2321-2330

1998

Volltextzugriff (PDF)

An integrated strategy for the discovery of drug targets by the analysis of protein–protein interactions

International journal of mass spectrometry, 2004-11, Vol.238 (2), p.119-130

2004

Volltextzugriff (PDF)

1 – 25 von 1.578

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.433)
Mit Volltextzugriff
(1.290)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.073)
Life Sciences & Biomedicine
(903)
Humans
(678)
Biological And Medical Sciences
(434)
Male
(434)
Female
(426)
Animals
(322)
Medical Sciences
(311)
Adult
(244)
Middle Aged
(226)
Aged
(180)
Fundamental And Applied Biological Sciences. Psychology
(156)
Mice
(135)
Neurosciences & Neurology
(123)
Neurosciences
(107)
Physical Sciences
(103)
Adolescent
(102)
Surgery
(95)
Immunology
(92)
Biochemistry & Molecular Biology
(88)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

JAVELIN renal 101: A randomized, phase III study of avelumab + axitinib vs sunitinib as first-line treatment of advanced renal cell carcinoma (aRCC)

Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial

Improved Expression in Hematopoietic and Lymphoid Cells in Mice After Transplantation of Bone Marrow Transduced With a Modified Retroviral Vector

Peptide Delivery to Tissues via Reversibly Linked Protein Transduction Sequences

Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells

The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion

In vivo restoration of laminin 5 beta 3 expression and function in junctional epidermolysis bullosa

Consistent, Persistent Expression from Modified Retroviral Vectors in Murine Hematopoietic Stem Cells

Sustainable systemic delivery via a single injection of lentivirus into human skin tissue

Validation of biomarkers to predict response to immunotherapy in cancer: Volume I — pre-analytical and analytical validation

Viral antigen stimulation of the production of human monokines capable of regulating HIV1 expression

908PDPrimary renal tumour shrinkage in patients (pts) who did not undergo upfront cytoreductive nephrectomy (uCN): Subgroup analysis from the phase III JAVELIN Renal 101 trial of first-line avelumab + axitinib (A + Ax) vs sunitinib (S) for advanced renal cell carcinoma (aRCC)

910PDEfficacy and biomarker analysis of patients (pts) with advanced renal cell carcinoma (aRCC) with sarcomatoid histology (sRCC): Subgroup analysis from the phase III JAVELIN renal 101 trial of first-line avelumab plus axitinib (A + Ax) vs sunitinib (S)

LBA6_PRJAVELIN renal 101: A randomized, phase III study of avelumab + axitinib vs sunitinib as first-line treatment of advanced renal cell carcinoma (aRCC)

Validation of biomarkers to predict response to immunotherapy in cancer: Volume II — clinical validation and regulatory considerations

Use of human tissue to assess the oncogenic activity of melanoma-associated mutations

Erratum to ‘Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial’: [ESMO Open Volume 6, Issue 3, June 2021, 100101]

Impact of Laminin 5 beta 3 Gene versus Protein Replacement on Gene Expression Patterns in Junctional Epidermolysis Bullosa

In vivo Restoration of Laminin 5 β3 Expression and Function in Junctional Epidermolysis Bullosa

High-Resolution Analysis of Cytosine Methylation in the 5′ Long Terminal Repeat of Retroviral Vectors

Selective in vitro and in vivo anti-tumor activity of PRLX 93936 in biological models of melanoma and ovarian cancer

Impact of laminin 5 beta3 gene versus protein replacement on gene expression patterns in junctional epidermolysis bullosa

Genetic associations with adverse events from anti-tumor necrosis factor therapy in inflammatory bowel disease patients

High-resolution analysis of cytosine methylation in the 5ĺong terminal repeat of retroviral vectors

An integrated strategy for the discovery of drug targets by the analysis of protein–protein interactions

Suchergebnisse filtern